Glavine Paul purchased $1.0M of HELP
Glavine Paul (Chief Growth Officer) purchased 90,000 shares of CYBIN INC. (HELP) at $11.59 ($1.04M total) on 2026-08-31.
How this was made
The 30-second read
Why it matters
The $1.04M purchase by the Chief Growth Officer adds to his existing large stake, indicating strong confidence in Cybin's prospects.
Market read
Insider buying of this magnitude can trigger short‑term buying interest and may influence analyst sentiment.
What to watch
Potential upcoming clinical trial results or regulatory filings not disclosed in the Form 4.
Background
Form 4 filings disclose insider trades; C‑level purchases are closely watched by traders for sentiment cues.
Ticker impact
Chief Growth Officer Glavine Paul bought 90,000 shares of Cybin Inc. for $1.04M, increasing his stake to over 4 million shares.
Potential modest upward pressure as market absorbs the insider buying signal.
C‑level insider purchases are viewed as strong bullish cues, especially when the transaction size exceeds $1M.
Market effects
May boost sentiment for biotech and pharma sector peers as insider confidence spreads.
Limited to US biotech market; no broader regional effect.
Minimal global impact beyond sector perception.
Counterpoint
Insider buying could be a window dressing move ahead of upcoming dilution or negative news.
Key entities
- CompanyCybin Inc.
Biopharma company developing psychedelic therapeutics.
- ExecutiveGlavine Paul
Chief Growth Officer of Cybin Inc.